Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for saphenous nerve blockade in ACL reconstruction
DRKS00010109Phase 2Active, not recruiting
- Sponsor
- UKH Salzburg
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in anterior cruciate ligament injury comparing Ropivacaine + dexmedetomidine with Ropivacaine + saline placebo (2 arms). Started Mar 2016; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on DRKS00010109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00010109.